Organization Overview
Historical Acquisition Tree
Alternative names
Key: ICON (2) Acquired (9)
Key: ICON (24) Acquired (56)
aluminum hydroxide (Gaviscon) (1 trial)
atorvastatin (lipitor) (2 trials)
bendamustine (treanda) (1 trial)
bremelanotide (Vyleesi) (2 trials)
brivaracetam (briviact) (3 trials)
budesonide (rhinocort) (1 trial)
carbamazepine (tegretol) (2 trials)
carboplatin (paraplatin) (3 trials)
certolizumab pegol (cimzia) (3 trials)
cisplatin (platinol) (2 trials)
dapagliflozin (farxiga) (1 trial)
drospirenone (Yasmin) (3 trials)
dydrogesterone (gynorest) (1 trial)
escherichia coli nissle 1917 (1 trial)
fibrinogen (human) (RiaSTAP) (2 trials)
filgrastim (neupogen) (2 trials)
fluticasone (cutivate) (5 trials)
gemcitabine (gemzar) (5 trials)
glatiramer acetate (copaxone) (3 trials)
immune globulin (human) (1 trial)
lacosamide (vimpat) (2 trials)
lenalidomide (revlimid) (2 trials)
levetiracetam (keppra) (2 trials)
lubiprostone (amitiza) (1 trial)
mucopolysaccharide polysulphate (1 trial)
naproxen (naprosyn) (3 trials)
necitumumab (portrazza) (1 trial)
onasemnogene abeparvovec (Zolgensma) (1 trial)
potassium perchlorate (perchloracap) (1 trial)
prednisone (meticorten) (3 trials)
progesterone (progestasert) (3 trials)
propionyl l-carnitine (1 trial)
propofol (diprivan) (2 trials)
rituximab (rituxan) (3 trials)
rosuvastatin (crestor) (2 trials)
sipuleucel-t (provenge) (1 trial)
sucroferric oxyhydroxide (velphoro) (2 trials)
tacrolimus (prograf) (2 trials)
Key: ICON (35) Acquired (69)
anti-cd19/20-car vector-transduced t cells (2 trials)
azithromycin (zithromax) (1 trial)
bexarotene (targretin) (1 trial)
bezlotoxumab (zinplava) (1 trial)
ceftaroline fosamil (teflaro) (1 trial)
dasatinib (sprycel) (2 trials)
durvalumab (imfinzi) (2 trials)
emapalumab-lzsg (gamifant) (2 trials)
erlotinib (tarceva) (2 trials)
metronidazole (flagyl) (1 trial)
nicotine (nicorette) (1 trial)
oxaliplatin (eloxatin) (1 trial)
pembrolizumab (keytruda) (3 trials)
phenytoin (mesantoin) (1 trial)
pioglitazone (actos) (1 trial)
polatuzumab vedotin (Polivy) (1 trial)
Key: ICON (46) Acquired (89)
apalutamide (erleada) (1 trial)
apolipoprotein kringle v (1 trial)
aripiprazole (abilify) (3 trials)
azelastine (astelin) (2 trials)
bupropion (wellbutrin) (1 trial)
cad3-marburg vaccine (1 trial)
diltiazem (cardizem) (1 trial)
donepezil (aricept) (2 trials)
dornase alfa (pulmozyme) (1 trial)
duvelisib (copiktra) (4 trials)
enoxaparin (lovenox) (1 trial)
estradiol (progynon depot) (1 trial)
flurbiprofen (ansaid) (1 trial)
humanised anti-cd22 antibody (1 trial)
itraconazole (sporanox) (3 trials)
lidocaine (xylocaine) (3 trials)
metoprolol (lopressor) (2 trials)
mirabegron (myrbetriq) (1 trial)
montelukast (singulair) (1 trial)
moxifloxacin (avelox) (1 trial)
omeprazole (prilosec) (2 trials)
oxycodone (oxycontin) (6 trials)
oxymetazoline (ocuclear) (2 trials)
Key: ICON (1) Acquired (2)
Afibrinogenemia (Phase 3)
Alzheimer Disease (Phase 2)
Amenorrhea (Phase 2)
Amyotrophic Lateral Sclerosis (Phase 2)
Anemia (Phase 3)
Anemia, Iron-Deficiency (Phase 4)
Anus Neoplasms (Phase 1)
Arthritis (Phase 1)
Arthritis, Rheumatoid (Phase 1)
Brain Injuries (Phase 3)
Brain Injuries, Traumatic (Phase 3)
Breast Neoplasms (Phase 1)
Carcinoma (Phase 1)
Carcinoma, Basal Cell (Phase 1)
Carcinoma, Neuroendocrine (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 1)
Carcinoma, Squamous Cell (Phase 1)
Cardiovascular Diseases (Phase 3)
Cataract (Phase 3)
Cholangiocarcinoma (Phase 1)
Choroidal Neovascularization (Phase 2)
Chronic Pain (Phase 1)
Cicatrix (Phase 2)
Cognitive Dysfunction (Phase 1)
Colorectal Neoplasms (Phase 1)
Communicable Diseases (Phase 3)
Congenital Abnormalities (Phase 3)
Coronary Artery Disease (Phase 3)
Coronary Disease (Phase 3)
Crohn Disease (Phase 2)
Cystic Fibrosis (Phase 1)
Deficiency Diseases (Phase 3)
Dementia (Phase 2)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 2 (Phase 3)
Diabetic Neuropathies (Phase 2)
Digestive System Neoplasms (Phase 1)
Endometrial Neoplasms (Phase 1)
Epilepsy (Phase 3)
Esophagitis (Phase 3)
Fallopian Tube Neoplasms (Phase 1)
Fatty Liver (Phase 2)
Fibrosis (Phase 1)
Gastrointestinal Neoplasms (Phase 1)
Heart Failure (Phase 4)
Hemorrhagic Fever, Ebola (Phase 1)
Hepatitis (Phase 2)
Hepatitis A (Phase 2)
Hepatitis B (Phase 2)
Hepatitis B, Chronic (Phase 2)
Hidradenitis (Phase 2)
Hidradenitis Suppurativa (Phase 2)
Histiocytoma, Malignant Fibrous (Phase 1)
Hypertension, Pulmonary (Phase 4)
Infections (Phase 3)
Inflammation (Phase 3)
Insulin Resistance (Phase 1)
Irritable Bowel Syndrome (Phase 2)
Kidney Diseases (Phase 3)
Leukemia (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 1)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Lung Neoplasms (Phase 3)
Lupus Erythematosus, Systemic (Phase 2)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, Follicular (Phase 1)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Non-Hodgkin (Phase 2)
Macular Degeneration (Phase 2)
Malaria (Phase 1)
Malaria, Falciparum (Phase 1)
Melanoma (Phase 3)
Mesothelioma (Phase 1)
Motor Neuron Disease (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myocardial Ischemia (Phase 3)
Nasopharyngeal Carcinoma (Phase 1)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 1)
Neovascularization, Pathologic (Phase 2)
Neuroendocrine Tumors (Phase 1)
Neutropenia (Phase 3)
Non-alcoholic Fatty Liver Disease (Phase 2)
Osteogenesis Imperfecta (Phase 2)
Ovarian Neoplasms (Phase 1)
Pain (Phase 2)
Pain, Postoperative (Phase 3)
Pancreatic Neoplasms (Phase 3)
Peripheral Nervous System Diseases (Phase 2)
Peritoneal Neoplasms (Phase 1)
Polyneuropathies (Phase 3)
Polyradiculoneuropathy (Phase 3)
Preleukemia (Phase 3)
Premature Birth (Phase 2)
Premature Ejaculation (Phase 2)
Renal Insufficiency, Chronic (Phase 3)
Reperfusion Injury (Phase 2)
Respiratory Syncytial Virus Infections (Phase 1)
Rhinitis (Phase 1)
Rhinitis, Allergic (Phase 1)
Sarcoma (Phase 1)
Sclerosis (Phase 2)
Small Cell Lung Carcinoma (Phase 1)
Small Fiber Neuropathy (Phase 1)
Squamous Cell Carcinoma of Head and Neck (Phase 1)
ST Elevation Myocardial Infarction (Phase 2)
Syndrome (Phase 3)
Thymoma (Phase 1)
Tooth, Impacted (Phase 2)
Triple Negative Breast Neoplasms (Phase 1)
Ulcer (Phase 3)
Urinary Bladder, Overactive (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Varicose Veins (Phase 2)
Virus Diseases (Phase 1)
Vulvar Neoplasms (Phase 1)
Wounds and Injuries (Phase 3)
